Skip to main content
OpenTrials

Clinical trial condition

Prostatic Diseases

Explore clinical trials studying Prostatic Diseases. Study availability and eligibility vary by location and protocol.

5,330 public trials 1,043 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Diseases trial results

Active, Not Recruiting

Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy

NCT05746806

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Universitätsspital Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana-Ente Ospedaliero Cantonale (IOSI-EOC) Bellinzona, Switzerland
  • Inselgruppe AG, Inselspital Bern, Switzerland
  • Kantonsspital Winterthur, Klinik für Radio-Onkologie Winterthur, Switzerland
View Trial Details
Active, Not Recruiting

Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)

NCT03383016

Conditions
Epidemiology, Genital Diseases, Genital Diseases, Male, +12 more
Locations
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada
  • McGill University Health Center Montreal, Quebec, Canada
  • CHU de Quebec- Université Laval Québec, Quebec, Canada
  • Centre de recherche du Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada
View Trial Details
Active, Not Recruiting

A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

NCT03809000

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
  • Arizona Center for Cancer Care - Peoria Peoria, Arizona, United States
  • Arizona Center for Cancer Care - Phoenix Phoenix, Arizona, United States
  • Arizona Center for Cancer Care - Scottsdale East Scottsdale, Arizona, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

NCT02051218

Conditions
Bone Metastases, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • Klinikum Wels-Grieskrichen GmbH Wels, Austria
  • Uniklinik Düsseldorf, Urologische Klinik Düsseldorf, Germany
  • Universitätsklinikum Düsseldorf, Frauenheilkunde/Geburtshilfe Düsseldorf, Germany
View all 50 locations
View Trial Details

Related conditions